Hemorrhage incidence with low molecular weight heparin vs unfractionated heparin in patients with unstable angina or Non-Q-wave myocardial infarction
Cohen, M.; Demers, C.; Fromell, G.J.; Califf, R.M.; Turpie, A.G.G.; Gurfinkel, E.; Langer, A.; Fox, K.A.
Journal of the American College of Cardiology 29(2 Suppl A): 410A
1997
ISSN/ISBN: 0735-1097 Accession: 031668367
PDF emailed within 1 workday: $29.90
Related References
Eikelboom, J.W.; Anand, S.S.; Malmberg, K.A.; Weitz, J.; Ginsberg, J.S.; Yusuf, S. 1999: Unfractionated heparin and low-molecular-weight heparin in unstable angina and non-Q-wave myocardial infarction A meta-analysis Circulation 100(18): 1; 621Mark, D.B.; Cowper, P.A.; Berkowitz, S.D.; Davidson-Ray, L.; DeLong, E.R.; Turpie, A.G.; Califf, R.M.; Weatherley, B.; Cohen, M. 1998: Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction Circulation 97(17): 1702-1707
Kauw, F.H.; Cleophas, T.J.; Kalmansohn, R.B. 1998: Low molecular weight heparins better than unfractionated heparin in unstable coronary artery disease? Unstable angina pectoris/non-Q wave infarction a partly outpatient clinic condition? International Journal of Clinical Pharmacology and Therapeutics 36(7): 392-397
Choussat, R.; Montalescot, G. 1999: Low molecular weight heparin in unstable angina and myocardial infarction without Q wave Presse Medicale 28(21): 1128-1134
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Hirsh 1997: Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin for Treatment of Venous Thrombosis and Unstable Angina Journal of Thrombosis and Thrombolysis 4(3-4): 349-351
Mattioli, A.V.; Sormani, L.; Goedecke, L.; Molinari, R.; Castellani, E.T.; Mattioli, G. 1998: Comparison between a very low molecular weight heparin and unfractionated heparin in patients with unstable angina A pilot study Journal of the American College of Cardiology 31(2 Suppl A): 488A
Cohen, M.; Stinnett, S.; Fromell, G. 1998: Effect of low molecular weight heparin on prespecific patient subgroups with rest unstable angina or non-Q-wave myocardial infarction Circulation 98(17): I559
Bijsterveld, N.R.; Moons, A.H.; Meijers, J.C.M.; Tijssen, J.G.P.; Büller, H.R.; Levi, M.; Peters, R.J.G. 2002: Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin Journal of the American College of Cardiology 39(5): 811-817
Borja, J.; Olivella, P. 2000: Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction Medicina Clinica 115(15): 583-586
Bozovich, G.E.; Gurfinkel, E.P.; Antman, E.M.; Mccabe, C.H.; Mautner, B. 2000: Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time American Heart Journal 140(4): 637-642
Walsh, C.R.; Lloyd-Jones, D.M.; Camargo, C.A.; Giugliano, R.P.; O'Donnell, C.J. 2000: Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: Do the results apply to all patients? American Journal of Cardiology 86(9): 908-912
Goodman, S.G.; Barr, A.; Sobtchouk, A.; Cohen, M.; Fromell, G.J.; Laperrière, L.; Hill, C.; Langer, A. 2000: Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: The Canadian ESSENCE ST segment monitoring substudy Journal of the American College of Cardiology 36(5): 1507-1513
Grip, L.; Wallentin, L.; Dellborg, M.; Grande, P.; Halinen, M.; Myhre, E.; Ryden, L.; Swahn, E.; Swedberg, K.; Thygesen, K. 1996: Thrombin inhibition in myocardial ischaemia Low molecular weight thrombin inhibitor inogatran versus heparin for unstable angina and non-Q-wave myocardial infarction European Heart Journal 17(ABSTR Suppl ): 121
Lopez Sendon, J.; Antman, E.M.; Cohen, M.; Radley, D. 2000: Superiority of enoxaparin over unfractionated heparin in unstable angina/non-Q-wave myocardial infarction occurs early in treatment Results from the TIMI 11B-ESSENCE meta-analysis European Heart Journal 21(Abstract Suppl): 598
Baird, S.H.; Mcbride, S.J.; Trouton, T.G.; Wilson, C. 1998: Low molecular weight heparin versus unfractionated heparin following thrombolysis in myocardial infarction Journal of the American College of Cardiology 31(2 Suppl A): 191A
Peters, R.J. 2002: Low-molecular-weight heparin is as effective as unfractionated heparin for adjunctive treatment of ST-elevation myocardial infarction Evidence-based Cardiovascular Medicine 6(4): 129-130
Theroux, P.; Barr, E.; Snapinn, S.; Sax, F.L. 1999: Rise in C-reactive protein levels is suppressed with tirofiban + heparin but not with heparin alone in patients with unstable angina/non-Q-wave myocardial infarction Journal of the American College of Cardiology 33(2 Suppl A): 330A
Zhang, Y.; Wang, X.-k.; Yang, C.-m.; Liu, G.-y. 2004: Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction Di 1 Jun Yi da Xue Xue Bao 24(1): 81-84
Wang, X.-K.; Zhang, Y.; Yang, C.-M.; Wang, Y.; Liu, G.-Y. 2006: Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction Clinical Drug Investigation 26(6): 341-349